Sept 17-19, 2019
Parsippany, New Jersey Hilton Hotel

> 2017 Exhibitors

> 2016 Exhibitors

> 2014 Exhibitors

Download 2019 Exhibitor Manual

Download Exhibitor Electric Form

ChemOutsourcing Banner To Alert Contacts You’re Attending

2018 Exhibitor List

read: buyers and suppliers together

Exhibitor List As Of May 25, 2019

Look for exhibitors according to their first letter.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Show All


Lacamas Labs
LGC Standards
Liaoning Pharm

Lacamas Labs, Booth 77

LGC Standards, Booth 58

Liaoning Pharm, Booth 105

Founded In 1985, Liaoning Pharm are one state-owned enterprise with rights of foreign contract and GSP is specializing in: 

  1. Handling chemicals, pharmaceuticals, food additives, feed additives, plant extract, veterinary materials, intermediates and health products.
  2. Undertaking economic-technical cooperation of chemical and pharmaceutical line.
  3. Wholesale of chemicals and drugs.
  4. Marketing medical apparatus.


Lonza, Booth 65 [ company website ]

Lonza Pharma & Biotech provides global contract development and manufacturing services that enable pharma and biotech companies to bring medical innovations to patients in need. We are recognized for our technology platforms, innovative product and process design, problem-solving and extensive experience in advancing and commercializing promising molecules. Our technologies are closely aligned with today’s formulation challenges with exceptional capabilities in addressing bioavailability challenges, specialized drug delivery, and highly potent active pharmaceutical ingredient (HPAPI) development and manufacture.

Phase-appropriate manufacturing is in place for rapid feasibility assessments, early and late stage clinical trials and commercial manufacturing across our product offering: early and advanced intermediates, API / HPAPI, particle-engineered drug product intermediates, and specialized finished dosage forms. Integrated design, development and manufacturing capabilities provides the option of working with one partner throughout the drug development cycle accelerating timelines and reducing program complexity and risk.

We have helped to commercialize pioneering therapies and we continuously invest and innovate to meet your expectations also for future medicines. Our belief is that the best outcome – for you and for your patients – comes as a result of a successful collaboration. Together, we can solve the next challenge and bring your next medicine to life.